197 related articles for article (PubMed ID: 6848416)
21. [Prevention of viral hepatitis B in early infancy--specific anti-HBs immunoglobulins (HBIG)].
Tanabe M; Noguchi H; Tsuzuki K; Minowa S; Tsuyuki M; Itoh S
Nagoya J Med Sci; 1984 Mar; 46(1-4):41-7. PubMed ID: 6738679
[No Abstract] [Full Text] [Related]
22. [Current status of the problem of viral hepatitis B prophylaxis].
Golosova TV; Vlasikhina EM
Probl Gematol Pereliv Krovi; 1980 Sep; 25(9):49-55. PubMed ID: 6999496
[No Abstract] [Full Text] [Related]
23. Viral Hepatitis: a review.
Neimark S; Rogers AI
Am J Gastroenterol; 1982 Jun; 77(6):431-5. PubMed ID: 6283881
[No Abstract] [Full Text] [Related]
24. [Infectivity of hepatitis B].
Gerken G
Dtsch Med Wochenschr; 1996 Apr; 121(14):459. PubMed ID: 8665822
[No Abstract] [Full Text] [Related]
25. The relationship of hepatitis B e antigen, DNA polymerase activity, and titer of hepatitis B surface antigen with ongoing liver injury in chronic hepatitis B virus infection.
Perrillo R; Campbell C; Wellinghoff W; Gelb L
Am J Gastroenterol; 1982 Jul; 77(7):445-9. PubMed ID: 7091131
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of wildtype and pre-C HBV variants in HBsAg/anti-HBe positive carriers with chronic hepatitis delta virus infection.
Santantonio T; Jung MC; Monno L; Milella M; Iacovazzi T; Pastore G; Will H
Prog Clin Biol Res; 1993; 382():235-42. PubMed ID: 8502687
[No Abstract] [Full Text] [Related]
27. [E/anti-E system and viral hepatitis type B (a review of the literature)].
Viazov SO; Stakhanova VM; Anan'ev VA
Vopr Virusol; 1979; (1):5-11. PubMed ID: 84440
[No Abstract] [Full Text] [Related]
28. [Class-M antibodies to the nuclear antigen in chronic hepatitis B: their significance for the late prognosis].
Fedorchenko SV
Vopr Virusol; 1991; 36(1):69-71. PubMed ID: 1858360
[No Abstract] [Full Text] [Related]
29. Viremia profiles in hepatitis B virus carrier children with spontaneous e antigen seroconversion: a case of déjà vu?
Lin CL; Kao JH
Gastroenterology; 2007 Sep; 133(3):1052-3; author reply 1053-4. PubMed ID: 17854613
[No Abstract] [Full Text] [Related]
30. Hepatitis B virus infection in the acquired immunodeficiency syndrome.
Rustgi VK; Hoofnagle JH; Gerin JL; Gelmann EP; Reichert CM; Cooper JN; Macher AM
Ann Intern Med; 1984 Dec; 101(6):795-7. PubMed ID: 6497194
[No Abstract] [Full Text] [Related]
31. Differential localization of s and e antigens in hepatitis B virus-associated glomerulonephritis.
Ohba S; Kimura K; Mise N; Konno Y; Suzuki N; Miyashita K; Tojo A; Hirata Y; Uehara Y; Atarashi K; Goto A; Omata M
Clin Nephrol; 1997 Jul; 48(1):44-7. PubMed ID: 9247778
[TBL] [Abstract][Full Text] [Related]
32. Approaches to the treatment of hepatitis B virus and delta-related liver disease.
Thomas HC; Lever AM; Scully LJ; Pignatelli M
Semin Liver Dis; 1986 Feb; 6(1):34-41. PubMed ID: 2424091
[No Abstract] [Full Text] [Related]
33. Radioimmunoassay detection of IgM antibodies to the hepatitis B core antigen in HBsAg liver disease.
Lavarini C; Crivelli O; Smedile A; Farci P; Marinucci G; Muglia M; Rizzetto M
Boll Ist Sieroter Milan; 1982; 61(3):210-7. PubMed ID: 6985422
[TBL] [Abstract][Full Text] [Related]
34. Chronic type B hepatitis and the "healthy" HBsAg carrier state.
Hoofnagle JH; Shafritz DA; Popper H
Hepatology; 1987; 7(4):758-63. PubMed ID: 3301618
[No Abstract] [Full Text] [Related]
35. Hepatitis B markers among dialysis patients without hepatitis B surface antigen or antibody.
Kelly TJ; Sanchez TV; Patterson MJ; Mayor GH
Proc Clin Dial Transplant Forum; 1980; 10():165-8. PubMed ID: 7346842
[No Abstract] [Full Text] [Related]
36. Short-term prednisolone for inducing seroconversion from hepatitis B e antigen to antibody along with clinical improvement in patients with chronic active hepatitis type B.
Kumada H; Ikeda K; Yoshida A; Seto S; Tsukada T; Kojima M; Suzuki H; Mayumi M
Jpn J Med; 1987 May; 26(2):217-22. PubMed ID: 3626161
[TBL] [Abstract][Full Text] [Related]
37. HBeAg and anti-HBe in chronic hepatitis B virus infection.
Chen DS; Sung JL; Lai MY
Gastroenterology; 1981 Apr; 80(4):880-2. PubMed ID: 7202958
[No Abstract] [Full Text] [Related]
38. [Favorable outcome in chronic active hepatitis caused by B virus in childhood].
Cadrobbi P; Bortolotti F; Crivellaro C; Rugge M; Armigliato M; Realdi G; Bertaggia A
Minerva Pediatr; 1984 Jul; 36(13-14):685-9. PubMed ID: 6503897
[No Abstract] [Full Text] [Related]
39. Risk of transmission of hepatitis B to hospital personnel exposed to a chronic HBsAg carrier.
Quraishi ZA; Adler LM; Blais FX
J Am Osteopath Assoc; 1985 Sep; 85(9):576-9. PubMed ID: 4055445
[No Abstract] [Full Text] [Related]
40. [Circulating immune complex antigens of hepatitis B].
Pintera J
Cesk Gastroenterol Vyz; 1980 Jan; 34(1):1-11. PubMed ID: 7363342
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
